{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:01:50Z","timestamp":1790726510219,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":217,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02721","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T22:26:21Z","timestamp":1786227981000},"page":"e02721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adjunctive palivizumab with ribavirin for respiratory syncytial virus infection during the early peri-transplant period in adult allogenic hematopoietic stem cell transplant recipients: Case series"],"prefix":"10.1016","volume":"45","author":[{"given":"Latefah","family":"Aleshaiwi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrah","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-5803","authenticated-orcid":false,"given":"Mohsen","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bosaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-8209","authenticated-orcid":false,"given":"Hajar","family":"AlQahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-4626","authenticated-orcid":false,"given":"Abdulellah","family":"Almohaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2026.e02721_bib1","doi-asserted-by":"crossref","first-page":"325.e1","DOI":"10.1016\/j.jtct.2025.02.012","article-title":"Assessment of the immunodeficiency scoring index for predicting outcomes after respiratory syncytial virus infection in allogeneic stem cell transplant recipients","volume":"31","author":"Mic\u00f3-Cerd\u00e0","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.idcr.2026.e02721_bib2","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1093\/infdis\/jiaf503","article-title":"Respiratory virus infections and pulmonary impairment after allogeneic hematopoietic cell transplantation","volume":"233","author":"Cheng","year":"2026","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02721_bib3","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1038\/s41409-021-01462-z","article-title":"Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients","volume":"56","author":"Houist","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.idcr.2026.e02721_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jtct.2023.09.018","article-title":"American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients","volume":"29","author":"El Chaer","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.idcr.2026.e02721_bib5","article-title":"Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia","volume":"26","author":"von Lilienfeld-Toal","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02721_bib6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cmi.2023.04.021","article-title":"Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Manothummetha","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idcr.2026.e02721_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, A humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","author":"Connor","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.idcr.2026.e02721_bib8","doi-asserted-by":"crossref","first-page":"B41","DOI":"10.1016\/j.ajog.2023.10.046","article-title":"Society for maternal-fetal medicine statement: clinical considerations for the prevention of respiratory syncytial virus disease in infants","volume":"230","author":"Joseph","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.idcr.2026.e02721_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13276","article-title":"Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes","volume":"22","author":"Akhmedov","year":"2020","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02721_bib10","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2013-12-541359","article-title":"Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections","volume":"123","author":"Shah","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.idcr.2026.e02721_bib11","doi-asserted-by":"crossref","unstructured":"Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection - Sanders, SL - 2023 | Cochrane Library. https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009417.pub3\/full. Accessed 20 Jun 2026.","DOI":"10.1002\/14651858.CD009417.pub3"},{"key":"10.1016\/j.idcr.2026.e02721_bib12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-1768","article-title":"The use of intravenous palivizumab for treatment of persistent RSV infection in children with leukemia","volume":"130","author":"Santos","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.idcr.2026.e02721_bib13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e3181343b7e","article-title":"Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients","volume":"26","author":"Ch\u00e1vez-Bueno","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.idcr.2026.e02721_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/322043","article-title":"Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants","volume":"184","author":"Boeckh","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02721_bib15","unstructured":"Cber. FDA Label, PALIVIZUMAB for Intramuscular Administration. 1999."},{"key":"10.1016\/j.idcr.2026.e02721_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26667","article-title":"Intravenous palivizumab in respiratory syncytial virus infection after hematopoietic stem cell transplant in children","volume":"64","author":"Torres","year":"2017","journal-title":"Pediatr Blood Cancer"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:16:17Z","timestamp":1790723777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"alternative-id":["S2214250926002349"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02721","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive palivizumab with ribavirin for respiratory syncytial virus infection during the early peri-transplant period in adult allogenic hematopoietic stem cell transplant recipients: Case series","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02721"}}